Evidence map›Paper›PMID 36808717›Full record

ArticleCancer medicine2023

Psychosocial factors impacting barriers and motivators to cancer genetic testing.

Erika N Hanson, Emerson Delacroix, Sarah Austin, Grant Carr, Kelley M Kidwell, Elizabeth Bacon, Lynette Hammond Gerido, Jennifer J Griggs, Elena M Stoffel, Ken Resnicow

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Erika N HansonDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-5952-0962
Emerson DelacroixSchool of Public Health, Department of Health Behavior and Education, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0003-1045-7963
Sarah AustinDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Grant CarrSchool of Public Health, Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Kelley M KidwellSchool of Public Health, Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Elizabeth BaconCenter for Health Communications Research, Rogel Cancer Center, Michigan Medicine, Ann Arbor, Michigan, USA.ORCID 0000-0001-9029-8004
Lynette Hammond GeridoSchool of Public Health, Department of Health Behavior and Education, University of Michigan, Ann Arbor, Michigan, USA.
Jennifer J GriggsDepartment of Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Elena M StoffelDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Ken ResnicowSchool of Public Health, Department of Health Behavior and Education, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0003-1416-9627
University of Michigan · USMichigan Department of Health and Human Services · USMichigan Medicine · US

Funding

Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Innovative Approaches to Expand Cancer Genetic Screening and Testing for Patients & Families in a Statewide Oncology Network through Community, State, & Payer PartnershipsU01CA232827 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRIGGS, JENNIFER J, RESNICOW, KEN A. · 2020 to 2020
$4.0M
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trialR01CA287257 · NCI · UNIVERSITY OF CHICAGO · PI Fay Kastrinos, Sonia Kupfer · 2024 to 2026
$3.4M
University of Michigan Training Program in ELSI ResearchT32HG010030 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERTS, SCOTT · 2018 to 2022
$962k
NCI NIH HHS R01 CA287257NCI NIH HHS U01 CA232827NCI NIH HHS U01 CA232827-05NHGRI NIH HHS T32 HG010030NIDDK NIH HHS P30 DK092926
6 · The paper itself

Abstract

backgroundOnly a small proportion of patients who qualify for clinical genetic testing for cancer susceptibility get testing. Many patient-level barriers contribute to low uptake. In this study, we examined self-reported patient barriers and motivators for cancer genetic testing.

methodsA survey comprised of both new and existing measures related to barriers and motivators to genetic testing was emailed to patients with a diagnosis of cancer at a large academic medical center. Patients who self-reported receiving a genetic test were included in these analyses (n = 376). Responses about emotions following testing as well as barriers and motivators prior to getting testing were examined. Group differences in barriers and motivators by patient demographic characteristics were examined.

resultsBeing assigned female at birth was associated with increased emotional, insurance, and family concerns as well as increased health benefits compared to patients assigned male at birth. Younger respondents had significantly higher emotional and family concerns compared to older respondents. Recently diagnosed respondents expressed fewer concerns about insurance implications and emotional concerns. Those with a BRCA-related cancer had higher scores on social and interpersonal concerns scale than those with other cancers. Participants with higher depression scores indicated increased emotional, social and interpersonal, and family concerns.

conclusionsSelf-reported depression emerged as the most consistent factor influencing report of barriers to genetic testing. By incorporating mental health resources into clinical practice, oncologists may better identify those patients who might need more assistance following through with a referral for genetic testing and the response afterwards.

Indexed as

Genetic TestingNeoplasmsAdultAgedAged, 80 and overFemaleGenetic Predisposition to DiseaseHumansMaleMental HealthMiddle AgedYoung Adultbarriersgenetic testinghereditary cancermotivators

Identifiers

PMID36808717
PMCPMC10166953
OpenAlexW4321375757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.